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Abstract
A growing number of studies implicate the microbiome in the pathogenesis of intestinal inflammation. Previous work has
shown that adults with esophagitis related to gastroesophageal reflux disease have altered esophageal microbiota
compared to those who do not have esophagitis. In these studies, sampling of the esophageal microbiome was
accomplished by isolating DNA from esophageal biopsies obtained at the time of upper endoscopy. The aim of the current
study was to identify the esophageal microbiome in pediatric individuals with normal esophageal mucosa using a minimally
invasive, capsule-based string technology, the EnterotestTM. We used the proximal segment of the Enterotest string to
sample the esophagus, and term this the ‘‘Esophageal String Test’’ (EST). We hypothesized that the less invasive EST would
capture mucosal adherent bacteria present in the esophagus in a similar fashion as mucosal biopsy. EST samples and
mucosal biopsies were collected from children with no esophageal inflammation (n = 15) and their microbiome composition
determined by 16S rRNA gene sequencing. Microbiota from esophageal biopsies and ESTs produced nearly identical profiles
of bacterial genera and were different from the bacterial contents of samples collected from the nasal and oral cavity. We
conclude that the minimally invasive EST can serve as a useful device for study of the esophageal microbiome.
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Introduction
Recent studies of the human microbiome have provided robust
support for the important role of the microbiome in health and
disease [1,2]. Whereas a significant body of work defines the
intestinal microbiology, few studies have investigated the esoph-
ageal microbiome. To date, these studies utilized mucosal biopsy
samples that were obtained at the time of endoscopic procedures
[3,4,5,6,7,8]. While technically feasible, this methodology is
invasive, time consuming, costly, and carries potential complica-
tions. In addition, repeated and frequent sampling following
therapeutic interventions are impractical and the full character-
ization of esophageal mucosal microbiome is limited to a ,3 mm
section of procured tissue.
To address this issue, we utilized the proximal section of a
minimally invasive device, the EnterotestTM, to sample the
esophageal mucosal microbial microenvironment. This capsule-
based string technology involves the subject swallowing a weighted
gelatin capsule filled with a string in which the proximal end is
taped to the cheek and the trailing end, with the capsule attached,
travels to the duodenum. At the time of endoscopy, 12–18 hours
after string placement, the tape is removed from the cheek and the
string is retrieved. The aim of this study was to harvest adherent
secretions from the proximal portion of the string that was situated
in the esophagus and analyze ribosomal RNA gene sequences. We
hypothesized that analogous to fecal sampling, the intraluminal
contents in the esophagus would be reflective of the mucosal
microbial environment present on esophageal mucosal tissue.
Materials and Methods
Esophageal string test (EST)
This study was approved by the Colorado Multiple Institutional
Review Board (COMIRB). Written informed consent and HIPPA
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authorization were obtained from all participants or from parents
or legal guardians of participants younger than 18 years. Assent
was obtained from all participants under 18 years.
Children 7–20 years of age who were undergoing an endoscopy
with biopsy to determine causes of abdominal pain, vomiting,
growth failure, or dysphagia were enrolled in this study. Exclusion
criteria included a history of esophageal stricture, narrowing,
fundoplication, gelatin allergy or other co-morbidities with
increase risk (bleeding diatheses, connective tissue diseases) of
endoscopic complications. Review of endoscopic and pathology
records were performed to determine normal diagnoses. All
children with normal mucosal biopsies were included in this study
report.
The night prior to the endoscopy, subjects swallowed an
EnterotestTM capsule (Figure S1). This technology was developed
and began successful use in the 1970’s to identify small intestinal
infections (e.g. Giardia lamblia) [9,10,11] and was subsequently used
to sample gastric contents for Helicobacter pylori [12,13]. The
pediatric EnterotestTM consists of a weighted gelatin capsule filled
with 90 cm of nylon string. The proximal end of the string
(,10 cm) extrudes from one end of the capsule, which is held and
taped to the cheek after the capsule is swallowed. When
swallowed, the capsule deploys the capture material, the nylon
string, during its passage through the esophageal, gastric and
duodenal lumen and is finally released into the duodenum where it
eventually is passed in the stool. No food or medications were
consumed after the EST was in place. The EST was removed
before or just after induction of general anesthesia. Locations of
esophageal and gastric segments of the EST were determined
using a combination of pH indicator sticks supplied with the tests,
and by measuring the distance to the lower esophageal sphincter at
the time of endoscopy.
Microbiome identification
Mucosal biopsies were then obtained from the middle to distal
part of the esophagus. Nasal swabs, a 2 cm segment of oral string
and a 2 cm segment of the middle part of the esophageal string
were collected from each subject. Biopsies, swabs and string
samples were snap frozen in liquid nitrogen and kept at 280uC
until DNA extraction.
DNA from all samples was extracted using Qiagen DNAeasy
Extraction Kits for blood and tissue according to manufacturer’s
specifications (Qiagen, Valencia, CA). DNA was amplified in
triplicate with barcoded PCR primers that include adaptors for the
Roche 454 sequencing platform [14]. Negative PCR controls were
performed for each barcode, and PCR was repeated for any
sample where the negative control was positive. Amplicons were
pooled after normalization of DNA concentration [15], and
sequenced using the Roche 454 FLX platform according to
manufacturer’s specifications (Roche, Branford, CT). Sequence
data were assigned to samples of origin using bar code sequences
added during PCR, and screened for basic quality defects (short
sequences ,200 nucleotides in length, .1 sequence ambiguity,
best read with quality $20 over a 10-nucleotide moving window)
by the program BARTAB [16]. Non-bacterial sequences were
removed from datasets by requiring a close match with a bacterial
rRNA secondary structure model within Infernal [17]. Sequences
identified as potential chimeras by ChimeraSlayer [18] were also
removed from datasets. The Ribosomal Database Project Classi-
fier software was used to make taxonomic assignments [19].
Taxonomic information was used to construct sequence groups
with identical taxonomic rank, which were used for bacterial
community analyses, and to identify specific bacteria that were
differentially present between locations.
Statistical analyses
Microbiome DNA results obtained from mucosal biopsy
samples were considered the ‘‘gold standard’’ reference; micro-
biome results obtained from the EST samples were compared to
those obtained from the biopsies in all statistical analyses. We
defined common genera as $1% relative abundance in any
sample and rare genera as ,1% relative abundance in any
sample.
Descriptive statistics included common ecological parameters
such as Shannon diversity [20]. For individual taxa, the
percentage of samples where the taxa was present, and the
median value of the relative abundance, are presented. Compar-
isons between two groups were performed individually for each
taxa using the paired version of the two-part test and the negative
log p-values are displayed using the Manhattan plot [21]. The two-
part test is the sum of two squared tests statistics, one comparing
the proportion of non-zero counts and one comparing the medians
of the non-zero counts. All analyses were performed using SAS
Version 9.2 software (SAS Institute Inc.: Cary, NC, 2008).
Results
Sample collection
Fifteen subjects (female, n = 10) were enrolled in this study
ranging in age from 11 to 18 (median age of 15) with the following
ethnic diversity; twelve White, one Black, one Hispanic and one
other. Five subjects were on proton pump inhibitor (PPI) for
heartburn at the time of the study, two were on inhaled steroids for
asthma or rhinitis, three were on food elimination diet, and one
was on inhaled steroid in addition to PPI and food elimination
diet. All subjects had normal histological biopsy findings. Thirteen
nasal swabs and fifteen oral strings, ESTs and biopsies were
collected. Bacterial ribosomal RNA gene amplification products
from mucosal biopsies and from the nasal cavity, oral cavity and
EST were visualized by gel electrophoresis (Figure S2).
Microbiome complexity is similar in oral, nasal and
esophageal microenvironments
To determine the extent of the bacterial diversity of the different
microenvironments, we evaluated the number of phylum-level
taxa present in the oral, nasal and esophageal samples. No
significant differences in the complexity of microbiome diversity
were observed between the nasal swab, oral string or esophageal
biopsy or EST samples at this broad taxonomic level (Figure 1).
Variation in this pattern emerged at subphylum levels. In addition,
similar numbers of bacterial phyla occur in each location.
EST and mucosal biopsy capture similar bacterial
assemblages
To determine the ability of the EST to capture the esophageal
microbiome, we procured DNA samples from paired esophageal
mucosal biopsies and ESTs and then compared the sequence
patterns in each. As shown in Manhattan plots (Figure 2), only 2
statistically significant differences were identified in comparing
biopsy and EST, Pasteurella and Actinomyces. Pasteurella was increased
in EST samples compared to mucosal biopsies (P = 0.04), whereas
Actinomyces was detected more often in biopsy samples, although
only in small quantities (relative abundance less than 5%,
P= 0.04). These results support the use of the EST to sample
the microbiome as compared to the ‘‘gold standard’’, the mucosal
biopsy.
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Phylum-level contents of esophageal biopsy and EST
microbiomes are similar
We next compared the individual subject esophageal phyla
present in the matching mucosal biopsies and ESTs (Figure 3).
Individually, the relative abundance was similar for Actinobacteria,
Bacteroidetes, Firmicutes, Fusobacteria and Proteobacteria in both biopsy
and EST (Figure 3A). In addition, the aggregate compilation of
data from all subjects analyzed also showed virtually identical
patterns of relative abundance in these predominant phyla present
in biopsies and ESTs (Figure 3B).
Similar genera in the esophageal biopsy and EST
microbiomes
To determine whether a similar pattern of microbiome
population was present at the genus level, we again compared
the individual subjects EST and mucosal biopsy samples
(Figure 4A). Thirty-one genera were identified in both EST and
biopsy samples, with Streptococcus, Prevotella, and Veillonella being the
3 most common (Figure 4B–C). Comparison of the top 10 genera
present on 15 biopsies (Figure 4B) and corresponding ESTs
(Figure 4C) indicated that the composition was similar across the
two sample sources.
The overlap between the genera present on the biopsies and
the EST is higher than 75% (Figure 5). The number of genera
was higher on biopsies than on ESTs (97 vs. 49). The most
common genera defined as $1% relative abundance in any
samples were largely shared between the biopsy and EST
(Figure 5), with only three genera that were discordant (3 in
biopsy only, Table 1). Table 1 summarizes the common genera
identified in this study and the proportion of subjects where each
genus was identified along with the median relative abundance of
each group. Genera were ordered based on a composite rank of
proportion of samples positive and relative abundance indepen-
dently for the two sample types. Table 1 is ordered by the rank
present in the biopsy samples. Rare taxa were different, with a
large proportion identified in the biopsy only, 50 compared to 21
in EST (4 in EST only). Rare taxa represented only 2% of genera
in biopsy and 1% in EST. These rare genera were detected in
low numbers of samples (38/48, 79%, were seen in a single
sample).
Bacterial communities are different in the oral, nasal, and
esophageal microenvironments
We defined the bacterial community of each microenvironment
captured by the string and swabs. Comparisons of the microbiome
captured in oral cavity and EST samples reveal two genera
differences (Figure 6A); Prevotella was found in significantly higher
amounts in the EST (P= 0.002), whereas Neisseria was significantly
lower in ESTs (P= 0.03). In addition, comparisons of the
microbiome captured in the nasal cavity and EST samples
revealed significant differences across several phyla and genera
(Figure 6B). Finally, results with the nasal and oral microbiome
revealed multiple differences in these two locations (Figure 6C).
These results suggest that each of these microenvironments harbor
specific taxa that distinguish the sites, and importantly, that the
esophageal segment of the EST does not become contaminated by
the oral microbiome upon removal.
Discussion
As the role of the microbiota in the pathogenesis of disease
becomes increasingly evident, there is need for development of
new and less invasive tools with which to sample microbiomes in
specific microenvironments throughout the body [1]. Use of
mucosal biopsies has contributed to an emerging body of data
identifying changes in esophageal microbiome in both health and
disease [4,5,6,7,8,22]. In this study, we surveyed the microbiome
associated with normal non-inflamed mucosal biopsy samples the
‘‘gold standard’’ and the proximal section of the Enterotest or
Esophageal String Test (EST). Results from our studies contribute
to a growing body of research defining the esophageal microbiome
and provide strong evidence that the microbial composition
captured by the EST accurately reflects the microbiome as
compared to mucosal biopsy samples. The EST technique is less
costly and incurs less risk, while potentially providing a more
comprehensive view of the esophagus than is obtained with a more
Figure 1. Microbiome phylum-level diversity is similar in
esophageal, oral and nasal microenvironments. Microbiome
diversity was measured from DNA samples taken from the esophageal
mucosa, oral and nasal samples as identified using 454 pyrosequencing.
Each point represents the number of Taxa present in each sample. The
mean 6 standard error of the mean are presented.
doi:10.1371/journal.pone.0042938.g001
Figure 2. Esophageal genera captured on mucosal biopsies
and ESTs are similar. Bacterial taxa were compared from 15 matched
biopsy and EST samples, the negative log p-value from this comparison
is displayed for each taxa. The gray horizontal lines indicate significant
differences (p,0.05 and p,0.01). The phyla are represented in different
colors as in the key. Genera that were significantly different are
numbered. Numbers represent: 1, Actinomyces; 2, Pasteurella. 2, had
higher relative abundance in EST versus biopsy.
doi:10.1371/journal.pone.0042938.g002
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limited, single ,3 mm mucosal biopsy sample, as the EST
interrogates a significantly greater surface area of the esophagus.
We conclude that the EST is an appropriate tool with which to
assess the esophageal microbial microenvironment.
Several methods have been used to capture esophageal
microbiome samples but all have utilized endoscopy. Previous
studies measuring the esophageal microbiome from mucosal
biopsy sampling identified patterns of remarkable similarity to
that identified with the EST [4]. Consistent with these studies, our
results reveal that the predominant genera in the esophagus are
Streptococcus, Prevotella and Veillonella [3,4,5,6,8]. Esophageal aspi-
rates and esophageal brushing were able to capture similar
bacteria [6] [5]. While these later two techniques seek to procure
mucosal samples without biopsy, they both require upper
endoscopy to obtain samples. Thus, while each of these techniques
captures similar bacteria to the EST, the EST offers the benefit of
its minimally invasive nature.
Traditional culture techniques have been used to identify the
makeup of the esophageal microbiome, thus, leaving non-
cultivable bacteria unidentified [23]. Our study took advantage
of culture-independent sequencing techniques that are capable of
identifying many organisms in parallel, without prior knowledge of
growth requirements. This technique provides a more complete
catalog of the esophageal microbial community as a reference for
future studies.
Figure 3. Esophageal phyla captured on mucosal biopsies and
ESTs are similar. A. Bar graphs indicate phylum detected in 15
matched biopsy (B) and EST samples (E) with each line corresponding to
one subject sample. Each phylum is indicated in a different color. The
width of the bar corresponds to the relative phylum abundance. B. Bar
graphs present the aggregate of all subjects (1–15) of the relative
phylum abundance detected in biopsies (B) and ESTs (E).
doi:10.1371/journal.pone.0042938.g003
Figure 4. Similar genera in the esophageal biopsy and EST
microbiomes. A. Bar graphs indicate genera detected in 15 matched
biopsy (B) and EST samples (E) with each line corresponding to one
subject sample. Each genus is indicated in a different color. The width
of the bar corresponds to the relative genus abundance. B. Pie chart
composed of the 10 most prevalent genera in biopsies (n = 15). C. Pie
chart composed of the 10 most prevalent genera in ESTs (n = 15). The
average percentage of each genus is indicated based on the total
bacterial population measured.
doi:10.1371/journal.pone.0042938.g004
Figure 5. Percentage of common genera captured on mucosal
biopsies and ESTs. Venn diagram indicating the overlap between
biopsies and ESTs for the common genera identified ($1% relative
abundance).
doi:10.1371/journal.pone.0042938.g005
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Direct comparisons of the microbiome in the nasal, oral and
esophageal cavities have not been previously reported. While one
might expect that the intimate anatomical connections of these
organs would lend to their possessing similar microbiomes, our
results and that of others have indicated that the nasal microbiome
[24,25] is distinct from the oral and esophageal microbiomes [5].
Our study compared all three bacterial assemblages simultaneous-
ly, and found that despite some similarities between sites, distinct
differences occur in the normal, oral and nasal cavity, and the
esophagus. Whether this trend holds during inflammatory
processes, awaits further study.
Over the last decade, a growing body of knowledge has
demonstrated the influence of the gastrointestinal microbiome on
health and disease. For instance, alterations of the colonic
microbiome have been associated with Crohn’s disease as well as
obesity [26,27,28,29]. Although such studies indicate potential
roles of the colonic microbiome in colonic disease, much less is
known about the role of the microbiome in the esophagus. A
critical issue has been access to specimens for analysis of
esophageal microbiology. In contrast to the relative ease in
obtaining fecal samples, human studies of the rest of the
gastrointestinal tract rely primarily on samples obtained through
mucosal biopsies at the time of endoscopy. Repeated sampling of
anatomical spaces is required to address stability since the
microbiome can change over time and with treatments [30,31].
Access to esophageal luminal contents with minimally invasive
Table 1. Prominent Genera of Esophageal Microbiome.
Biopsy EST
Phyla Genera Rank Median
Percent
Detected* Rank Median
Percent
Detected* Disagreement (%){
Firmicutes Streptococcus 1 38.7 100 1 35.3 100 0
Bacteroidetes Prevotella 2 15.5 100 2 25.6 100 0
Firmicutes Veillonella 3 5.1 100 3 7.7 100 0
Proteobacteria Haemophilus 4 2.1 100 5 2.5 100 0
Proteobacteria Pasteurella 5 1.6 100 4 3.3 100 0
Bacteroidetes Porphyromonas 6 1.4 100 9 1.8 80 20
Firmicutes Granulicatella 7 1.0 100 8 1.0 87 13
Fusobacteria Fusobacterium 8 2.1 93 6 2.8 87 30
Proteobacteria Neisseria 9 0.6 93 10 0.5 67 40
Firmicutes Gemella 10 0.6 93 7 0.9 93 13
Actinobacteria Rothia 11 0.7 73 15 0.1 53 47
Fusobacteria Leptotrichia 12 0.7 73 11 0.3 67 33
Proteobacteria Campylobacter 13 0.5 87 13 0.2 60 40
Actinobacteria Actinomyces 14 0.5 80 16 0 47 47
Firmicutes Oribacterium 15 0.3 60 12 0.2 67 33
Firmicutes Solobacterium 16 0.2 60 18 0 33 40
Actinobacteria Atopobium 17 0.2 53 19 0 27 53
Firmicutes Megasphaera 18 0.2 53 21 0 20 33
Firmicutes Peptostreptococcus 19 0.1 53 22 0 20 60
Bacteroidetes Capnocytophaga 20 0 47 17 0 47 27
Proteobacteria Pseudomonas 21 0 47 27 0 7 40
Proteobacteria Aggregatibacter 22 0 40 14 0.1 53 27
Tenericutes Mycoplasma 23 0 27 28 0 7 20
Proteobacteria Delftia 24 0 20 30 0 nd 20
Proteobacteria Kingella 25 0 20 23 0 20 27
Proteobacteria Phocoenobacter 26 0 20 24 0 13 20
Proteobacteria Stenotrophomonas 27 0 20 31 0 nd 20
Fusobacteria Streptobacillus 28 0 13 20 0 27 13
Proteobacteria Bibersteinia 29 0 13 26 0 7 7
Proteobacteria Bradyrhizobium 30 0 13 29 0 nd 13
Fusobacteria Sneathia 31 0 7 25 0 7 0
*Percentage of samples that contained the genus.
{Disagreement between paired EST and biopsy samples.
In bold are the genera significantly different between the biopsy and the EST.
This table lists the top 20 genera in rank of median relative abundance. Also featured are the percentage detection and disagreement from the 15 individual biopsies
and ESTs, (nd, not detected).
doi:10.1371/journal.pone.0042938.t001
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collection, as with the EST, will allow more sampling opportu-
nities for exploring upper gastrointestinal tract diseases.
In the current study, some of the subjects were on various
treatments (PPI, steroids, restricted diet) at the time of sample
collection that could affect the microbiome as compared to normal
individuals without any treatment: e.g., the use of PPIs was found
to increase the bacterial load on esophageal biopsies [32].
Furthermore, steroid responsiveness has been associated with the
microbiome in inflammatory bowel diseases [33]. Diet is another
factor that is known to influence the microbiota [28,34].
Dentogingival health may also affect the oral microbiome [35]
and potentially the esophageal microbiome. However, the goal of
this study was to determine if the EST could accurately reflect the
mucosal microbiome, and we did not have adequate power to
determine the effect of a specific treatment on the esophageal
microbiota. Larger studies, facilitated by the EST, will address this
issue as adequate numbers of subjects without esophageal
involvement are recruited.
Overall, the EST was well tolerated in our study, with gagging
noted as the only side effect in some subjects. Contamination from
adjacent sites is possible, but our results suggest clear differences in
the microbiota. Consistent with previous studies our results show
that, some bacteria found in the normal oral cavity, such as
Spirochetes and Deferribacteres [36], are not conspicuous in the normal
esophagus [5]. Our study included a larger number of females
than males, but we saw no influence of gender on our findings.
However, it has been reported that in the absence of disease,
similar phylum level patterns are observed in the esophageal and
gastric compartment independent of ethnicity or gender [36].
Rare genera were detected more frequently in biopsy samples
than on the EST, and there are several possible explanations for
this observation. The EST is able to capture microbiome from a
greater esophageal surface area, and thereby increase the signal
from common genera and making detection of rare genera less
frequent with EST samples. Further, it is possible that different
taxa have variable affinities for the mucosa, perhaps affecting the
ability of the string to capture them. Additionally, the overnight
placement of the string in the esophagus may allow particular
genera to proliferate and thereby alter relative abundances seen
molecularly.
In conclusion, the EST is a novel, minimally invasive device
with which to sample the esophageal microbiome, with results
comparable to those obtained with esophageal biopsies. Use of the
device is particularly appropriate for children, as it obviates the
need for endoscopy and anesthesia. Easier sampling of the
esophageal lumen using the EST will facilitate future studies of
the esophageal microbiome in disease and health.
Supporting Information
Figure S1 Esophageal String Test. The EnterotestTM
capsule with the extruded string is shown. The top arrow shows
the portion of the string that is taped to the cheek. The bottom
arrow indicates the weighted capsule that is dislodged in the
duodenum.
(TIF)
Figure 6. Oral and nasal microbiomes differ from the
esophageal microbiome. DNA samples were taken from the oral,
nasal and EST and the microbiome identified using 454 pyrosequenc-
ing. Bacterial phyla are compared between biopsy and EST samples and
results displayed using Manhattan plot as follows. A. Esophagus (EST)
compared to the oral cavity, Genera that were significantly different are
numbered. Numbers represent: 1, Prevotella; 2, Neisseria. 1, had higher
relative abundance in EST. B. Esophagus (EST) compared to the nasal
cavity. Numbers represent 1, Corynebacterium; 2, Propionibacterium; 3
Porphyromonas; 4, Prevotella; 5, Staphylococcus; 6, Streptococcus; 7,
Veillonella; 8, Fusobacterium; 9, Haemophilus; 10, Pasteurella. Numbers 3,
4, 6–10 were higher in EST. C. Nasal cavity compared to the oral cavity.
Numbers represent: 1, Corynebacterium; 2, Propionibacterium; 3,
Porphyromonas; 4, Prevotella; 5, Staphylococcus; 6, Streptococcus; 7,
Veillonella; 8, Fusobacterium; 9, Aggregatibacterium; 10, Haemophilus; 11,
Pasteurella. Numbers 3, 4, 6–11 were higher in oral samples. Gray
horizontal lines indicate significant differences (p,0.05 and p,0.01).
Phyla are represented on the X-axis as different colors as in the key.
doi:10.1371/journal.pone.0042938.g006
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Figure S2 16S amplification and detection of oral, nasal
and esophageal microenvironments. This is a picture of a
representative 2% agarose gel with a 200 bp amplification product
from the V2–V3 region of the 16S rDNA gene. DNA samples
were obtained from nasal swabs, oral strings, ESTs and esophageal
biopsies.
(TIF)
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